Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1Phase 1 1

Status

Completed 8Unknown 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Conditions

Polycystic Ovary Syndrome 4Menstruation Disturbances 1Hyperandrogenism 1Hirsutism 1Amenorrhea 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 291Drug Therapy 277Bevacizumab 249apatinib 247camrelizumab 219Etoposide 201Irinotecan 183Doxorubicin 181Leucovorin 164Dexamethasone 161pembrolizumab 155Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × drospirenone and ethinyl estradiol combination × Clear all
NCT04831151 2022-05-19

The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics

Inonu University

Phase NA Unknown
42 enrolled

Amenorrhea, Hirsutism, Polycystic Ovary Syndrome

NCT02027337 2014-11-21

Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants

Tyumen State Medical Academy

Phase 4 Unknown
200 enrolled

Menstruation Disturbances, Polycystic Ovary Syndrome, Hyperandrogenism

NCT01603745 2012-05-22

Effects of Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol on Cardiovascular Risk in Women With Polycystic Ovary Syndrome

Catholic University of the Sacred Heart

Phase 1 Unknown
10 enrolled

Polycystic Ovary Syndrome

NCT01459445 2011-10-25

Metformin+ Drospirenone/ethinylestradiol30µg and Flow-mediated Dilation in Polycystic Ovary Syndrome

Iuliu Hatieganu University of Medicine and Pharmacy

Phase NA Unknown
26 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡